1. Elander, B., Fellenius, E., Leth, R., Olbe, L. and Wallmark, B., Inhibitory action of omeprazole on acid formation in gastric glands and on H+, K+-ATPase isolated from human gastric mucosa.Scand. J. Gastroenterol., 21, 268–272 (1986).
2. Caldwell, S. H. and McCallum, R. W., Handbook of Experimental Pharmacology, In Clollen, M. J. and Benjamin, S. B. (Eds.),Hypothesis of peptic disease. Springer-Verlag, Berlin Heidelberg, pp. 189–227, 1991.
3. Classen, M., Damman, H. G., Domschke, W., Huttemannm, W., Longdong, W., Rehner, M., Simon, B., Witzel, L. and Berger, J., Omeprazole heals duodenal, but not gastric ulcers more rapidly than ranitidine.Hepatogastroenterology, 32, 243–245 (1985).
4. Dixon, M. and Webb, E. C., Enzymes, 3rd Ed., Longman, London, 1979.
5. Fellinius, E., Berglindh, T., Sachs, G., Olbe, L., Elander, B., Sjostrand, S. E., Wallmark, B., Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+,K+)-ATPase.Nature, 290, 159–161 (1981).